Hannover Re Common Stock (HNR1) Stock Price & News

HNR1:ETR

Hannover Re Common Stock

€272.00

+1.34%

(+3.60) 1D

Oct 15, 5:35:56 PM GMT+2 · EUR

All symbols

	Symbol	Price	Change	% Change

Last report

Aug 12, 2026

Fiscal period

Q2 2026

€5.77 / €5.37

+7.50%beat

Revenue / Est. (EUR)

5.51B / 6.42B

-14.21%miss

Fiscal Q2 2026 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in EUR

Loading Previous Earnings...

All values in EUR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	5.72B	5.93B	5.53B	5.51B
Cost of goods sold	4.64B	4.73B	4.55B	4.62B
Cost of revenue	4.64B	4.73B	4.55B	4.62B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	-	-	-	-
Operating expense	187.80M	80.00M	398.60M	108.60M
Total operating expenses	4.82B	4.81B	4.95B	4.73B
Operating income	892.30M	1.12B	576.50M	780.00M
Other non operating income	12.80M	-11.60M	-100.00K	100.00K
EBT including unusual items	716.60M	986.00M	949.60M	939.70M
EBT excluding unusual items	716.60M	991.90M	949.60M	939.70M
Income tax expense	36.80M	234.50M	204.30M	206.50M
Effective tax rate	5.14%	23.78%	21.51%	21.98%
Other operating expenses	170.10M	41.00M	380.90M	95.10M
Net income	650.80M	676.70M	710.60M	695.30M
Net profit margin	11.39%	11.40%	12.86%	12.62%
Earnings per share	5.40	5.61	5.89	5.77
Interest and investment income	-	-	-	-
Interest expense	-21.70M	-60.20M	-21.40M	-21.60M
Net interest expenses	-21.70M	-60.20M	-21.40M	-21.60M
Depreciation and amortization charges	-	-46.70M	31.10M	-
EBITDA	908.30M	1.16B	591.20M	796.40M
Gain or loss from assets sale	-	-	-	-

Finance